Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 690567
                    [Title] => Clopidogrel plus aspirin cuts vascular events
                    [Summary] => 
Adding clopidogrel to aspirin therapy significantly reduces the risk of stroke and other major vascular events in patients who have atrial fibrillation and are not candidates for anticoagulation therapy with a vitamin K antagonist, according to the Population Health Research Institute in Hamilton, Ont.
                    [DatePublished] => 2011-05-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

ATRIAL FIBRILLATION CLOPIDOGREL TRIAL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 690567
                    [Title] => Clopidogrel plus aspirin cuts vascular events
                    [Summary] => 
Adding clopidogrel to aspirin therapy significantly reduces the risk of stroke and other major vascular events in patients who have atrial fibrillation and are not candidates for anticoagulation therapy with a vitamin K antagonist, according to the Population Health Research Institute in Hamilton, Ont.
                    [DatePublished] => 2011-05-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Clopidogrel plus aspirin cuts vascular events

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | May 29, 2011 - 12:00am

Adding clopidogrel to aspirin therapy significantly reduces the risk of stroke and other major vascular events in patients who have atrial fibrillation and are not candidates for anticoagulation therapy with a vitamin...

Opinion